Nirsevimab for RSV: A Breakthrough Product for Babies

MicrobeTV

P. Offit, V. Racaniello

IDWeek 2024 Insights: To Mask or Not to Mask - Approaches to Source …

IDWeek 2024 Insights

E. Landon

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

GI and Hepatic Complications of Cancer Immunotherapy

Michigan Medicine

R. Fontana

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Diego Hijano

Safety and Monitoring Considerations in Systematic Therapy

Masterclasses in Dermatology

J. Cohen

EASD Insights: Long-term Complications in Diabetes - From Classical …

Stephan Herzig

Top Risk Factors for Cancer by Sex and What to Do About It

MedCram

R. Seheult

Newly Licensed Respiratory Syncytial Virus Vaccines for Adults: What…

MicrobeTV

P. Offit, V. Racaniello

Monkeypox Declared a Public Health Emergency of International Concer…

MicrobeTV

D. Griffin, V. Racaniello

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

Unveiling the Facets of Post-Sepsis Syndrome: Physical and Neuropsyc…

Houston Methodist

D. Moran

September 2024 Public Health Infectious Disease Updates

California Medical Association

E. Pan

IDWeek 2024 Insights: COVID-19 in Children - Navigating the Current …

IDWeek 2024 Insights

I. Anosike

Comorbidities of Psoriasis and PsA

Masterclasses in Dermatology

J. Cohen

Update on Adult Immunizations (July 2024): Part 1

Barbara Yawn

IDWeek 2024 Insights: Management of Substance Use Disorders in HIV

IDWeek 2024 Insights

H. Hurley

Project 2025 vs. the Public's Health Part III: The NIH

MicrobeTV

P. Offit, V. Racaniello

CDC Changes COVID Policy

MicrobeTV

P. Offit, V. Racaniello

Update on Adult Immunizations (July 2024): Part 2

Barbara Yawn